Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4734127, 11 pages
https://doi.org/10.1155/2017/4734127
Research Article

Santamarine Inhibits NF-κB Activation and Induces Mitochondrial Apoptosis in A549 Lung Adenocarcinoma Cells via Oxidative Stress

1Department of Clinical Laboratory, Jilin Provincial Tumor Hospital, Changchun 130012, China
2Department of Abdominal Oncosurgery-2, Jilin Provincial Tumor Hospital, Changchun 130012, China
3College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning 116044, China

Correspondence should be addressed to Xiuyan Yu; moc.uhos@8691nayuixuy

Received 19 May 2017; Accepted 24 July 2017; Published 2 October 2017

Academic Editor: Noriyoshi Sawabata

Copyright © 2017 Xuefeng Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Roviello, “The distinctive nature of adenocarcinoma of the lung,” OncoTargets and Therapy, vol. 8, pp. 2399–2406, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. Marshall and D. C. Christiani, “Genetic susceptibility to lung cancer-light at the end of the tunnel?” Carcinogenesis, vol. 34, no. 3, pp. 487–502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Nan, Y. Du, X. Chen et al., “TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers,” Molecular Cancer Therapeutics, vol. 13, no. 3, pp. 617–629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Wu, Q. Chang, Y. Lu et al., “Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells,” Oncotarget, vol. 4, no. 12, pp. 2430–2438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Castoldi, J. Schanzer, C. Panke et al., “TetraMabs: Simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations,” Protein Engineering, Design and Selection, vol. 29, no. 10, pp. 467–475, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Dong, Q. Mao, W. Xia et al., “PKM2 and cancer: the function of PKM2 beyond glycolysis,” Oncology Letters, vol. 11, no. 3, pp. 1980–1986, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Li, G. Zhang, L. Zhao, Z. Ma, and H. Chen, “Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer,” World Journal of Surgical Oncology, vol. 14, article 15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Khan, A. Maryam, J. I. Qazi, and T. Ma, “Targeting apoptosis and multiple signaling pathways with icariside II in cancer cells,” International Journal of Biological Sciences, vol. 11, no. 9, pp. 1100–1112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Khan, A. Maryam, H. Zhang, T. Mehmood, and T. Ma, “Killing cancer with platycodin D through multiple mechanisms,” Journal of Cellular and Molecular Medicine, vol. 20, no. 3, pp. 389–402, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. K. H. Seo, H. W. Ryu, M. J. Park et al., “Mangosenone F, a furanoxanthone from garciana mangostana, induces reactive oxygen species-mediated apoptosis in lung cancer cells and decreases xenograft tumor growth,” Phytotherapy Research, vol. 29, no. 11, pp. 1753–1760, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Mehmood, A. Maryam, H. Zhang, Y. Li, M. Khan, and T. Ma, “Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction,” BioFactors, vol. 43, no. 1, pp. 63–72, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Li, Z.-Y. Ni, M.-C. Zhu et al., “Antitumour activities of sesquiterpene lactones from inula helenium and inula japonica,” Zeitschrift für Naturforschung C, vol. 67, pp. 375–380, 2012. View at Google Scholar
  13. F. S. El‐Feraly and Y. Chan, “Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L,” Journal of Pharmaceutical Sciences, vol. 67, no. 3, pp. 347–350, 1978. View at Publisher · View at Google Scholar · View at Scopus
  14. E. W. Coronado-Aceves, C. Velázquez, R. E. Robles-Zepeda et al., “Reynosin and santamarine: two sesquiterpene lactones from ambrosia confertiflora with bactericidal activity against clinical strains of mycobacterium tuberculosis,” Pharmaceutical Biology, vol. 54, no. 11, pp. 2623–2628, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-G. Choi, D.-S. Lee, B. Li, Y. H. Choi, S.-H. Lee, and Y.-C. Kim, “Santamarin, a sesquiterpene lactone isolated from Saussurea lappa, represses LPS-induced inflammatory responses via expression of heme oxygenase-1 in murine macrophage cells,” International Immunopharmacology, vol. 13, no. 3, pp. 271–279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Khan, T. Li, M. K. Ahmad Khan et al., “Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction,” BioMed Research International, vol. 2013, Article ID 719858, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Gach and A. Janecka, “α-methylene-γ-lactones as a novel class of anti-leukemic agents,” Anti-Cancer Agents in Medicinal Chemistry, vol. 14, no. 5, pp. 688–694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Khan, C. Ding, A. Rasul et al., “Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells,” International Journal of Biological Sciences, vol. 8, no. 4, pp. 533–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Chen, P. Zou, Z. Zhao et al., “Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation,” Oncotarget, vol. 7, no. 13, pp. 16593–16609, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Zou, Y. Xia, J. Ji et al., “Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer,” Cancer Letters, vol. 375, no. 1, pp. 114–126, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ghantous, H. Gali-Muhtasib, H. Vuorela, N. A. Saliba, and N. Darwiche, “What made sesquiterpene lactones reach cancer clinical trials?” Drug Discovery Today, vol. 15, no. 15-16, pp. 668–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Khan, F. Yi, A. Rasul et al., “Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction,” IUBMB Life, vol. 64, no. 9, pp. 783–794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Zhang, Y. Li, D. Duan, J. Yao, K. Gao, and J. Fang, “Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells,” Biochemical Pharmacology, vol. 102, pp. 34–44, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Chen, Z. Li, L. Bai, and Y. Lin, “NF-κB in lung cancer, a carcinogenesis mediator and a prevention and therapy target,” Frontiers in Bioscience (Landmark Edition), vol. 16, no. 3, pp. 1172–1185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Giopanou, I. Lilis, V. Papaleonidopoulos et al., “Comprehensive evaluation of nuclear factor-κB expression patterns in non-small cell lung cancer,” PLoS ONE, vol. 10, article e0132527, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. I. Körber, A. Staribacher, I. Ratzenböck, G. Steger, and R. M. Mader, “NF-κB-associated pathways in progression of chemoresistance to 5-fluorouracil in an in vitro model of colonic carcinoma,” Anticancer Research, vol. 36, pp. 1631–1639, 2016. View at Google Scholar · View at Scopus